Platelet desialylation is a novel mechanism and a therapeutic target in thrombocytopenia during sepsis: an open-label, multicenter, randomized controlled trial
Abstract Background Studies in murine models suggested that platelet desialylation was an important mechanism of thrombocytopenia during sepsis. Methods First, we performed a prospective, multicenter, observational study that enrolled septic patients with or without thrombocytopenia to determine the...
Main Authors: | Mei-feng Li, Xiao-li Li, Kai-liang Fan, Ying-yi Yu, Jing Gong, Shu-ying Geng, Ya-feng Liang, Ling Huang, Ji-hua Qiu, Xing-han Tian, Wen-ting Wang, Xiao-lu Zhang, Qing-xia Yu, Yuan-feng Zhang, Peng Lin, Li-na Wang, Xin Li, Ming Hou, Lu-yi Liu, Jun Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-05-01
|
Series: | Journal of Hematology & Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13045-017-0476-1 |
Similar Items
-
Platelet desialylation correlates with efficacy of first-line therapies for immune thrombocytopenia
by: Lili Tao, et al.
Published: (2017-02-01) -
Platelet desialylation and TFH cells–the novel pathway of immune thrombocytopenia
by: Yuwen Chen, et al.
Published: (2021-03-01) -
Platelet storage induces accelerated desialylation of platelets and increases hepatic thrombopoietin production
by: Jooyoung Cho, et al.
Published: (2018-07-01) -
Emerging Therapies in Immune Thrombocytopenia
by: Sylvain Audia, et al.
Published: (2021-03-01) -
Proatherogenic Sialidases and Desialylated Lipoproteins: 35 Years of Research and Current State from Bench to Bedside
by: Alexandre Mezentsev, et al.
Published: (2021-05-01)